Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00202891
Status:
WITHDRAWN
Last Update Posted:
2015-06-03
First Post:
2005-09-16
Brief Title:
Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas Study P04460
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas
Status:
WITHDRAWN
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No further local interest in pursuing the study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This open-label randomized parallel-group clinical study is designed to compare the efficacy and safety of the topical antibiotic sisomicin cream with that of another topical antibiotic cream nadifloxacin cream in the treatment of Indian patients with primary pyodermas
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None